Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ZFP386 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of ZFP386 mRNA | CTD | PMID:35192832 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZFP386 mRNA | CTD | PMID:33387578 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ZFP386 mRNA | CTD | PMID:26251327 | 3H-1,2-dithiole-3-thione | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of ZFP386 mRNA | CTD | PMID:19162173 | 6-propyl-2-thiouracil | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ZFP386 mRNA | CTD | PMID:30047161 | acetamide | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | acetamide results in decreased expression of ZFP386 mRNA | CTD | PMID:31881176 | aflatoxin B1 | decreases methylation | ISO | ZNF519 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ZNF519 gene | CTD | PMID:27153756 | aflatoxin B1 | increases methylation | ISO | ZNF519 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of ZNF519 intron | CTD | PMID:30157460 | aldehydo-D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of ZFP386 mRNA | CTD | PMID:17178593 | amitrole | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of ZFP386 mRNA | CTD | PMID:30047161 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ZFP386 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ZNF519 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | ZNF519 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZNF519 intron | CTD | PMID:30157460 | benzo[e]pyrene | increases methylation | ISO | ZNF519 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of ZNF519 intron | CTD | PMID:30157460 | bisphenol A | increases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ZFP386 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ZFP386 mRNA | CTD | PMID:35192832 | chlorpyrifos | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Chlorpyrifos results in decreased expression of ZFP386 mRNA | CTD | PMID:18668222 | copper atom | increases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Copper results in increased expression of ZFP386 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Copper results in increased expression of ZFP386 mRNA | CTD | PMID:30556269 | copper(II) sulfate | increases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of ZNF519 mRNA | CTD | PMID:19549813 | D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of ZFP386 mRNA | CTD | PMID:17178593 | dichloromethane | increases expression | EXP | | 6480464 | Methylene Chloride results in increased expression of ZFP386 mRNA | CTD | PMID:28392392 | dorsomorphin | multiple interactions | ISO | ZNF519 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | decreases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | entinostat results in decreased expression of ZNF519 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | ZNF519 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF519 mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of ZNF519 mRNA | CTD | PMID:23649840 | flavonoids | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Flavonoids results in decreased expression of ZFP386 mRNA | CTD | PMID:18035473 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of ZFP386 mRNA | CTD | PMID:25629700 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of ZFP386 mRNA | CTD | PMID:32186404 | gentamycin | increases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of ZFP386 mRNA | CTD | PMID:22061828 | gentamycin | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ZFP386 mRNA | CTD | PMID:33387578 | glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of ZFP386 mRNA | CTD | PMID:17178593 | hydralazine | multiple interactions | ISO | ZNF519 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ZNF519 mRNA | CTD | PMID:17183730 | indole-3-methanol | affects expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | indole-3-carbinol affects the expression of ZFP386 mRNA | CTD | PMID:21396975 | methapyrilene | increases methylation | ISO | ZNF519 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of ZNF519 intron | CTD | PMID:30157460 | methimazole | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of ZFP386 mRNA | CTD | PMID:30047161 | methotrexate | increases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of ZNF519 mRNA | CTD | PMID:24449571 | methylmercury chloride | decreases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ZNF519 mRNA | CTD | PMID:28001369 | nefazodone | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | nefazodone results in decreased expression of ZFP386 mRNA | CTD | PMID:24136188 | nickel atom | decreases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | Nickel results in decreased expression of ZNF519 mRNA | CTD | PMID:24768652 | nimesulide | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | nimesulide results in decreased expression of ZFP386 mRNA | CTD | PMID:24136188 | panobinostat | multiple interactions | ISO | ZNF519 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF519 mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of ZNF519 mRNA | CTD | PMID:26272509 | paracetamol | increases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ZNF519 mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ZFP386 mRNA | CTD | PMID:33387578 | pentachlorophenol | decreases expression | EXP | | 6480464 | Pentachlorophenol results in decreased expression of ZFP386 mRNA | CTD | PMID:23892564 | pentanal | decreases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | pentanal results in decreased expression of ZNF519 mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of ZFP386 mRNA | CTD | PMID:19162173 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ZFP386 mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | perfluorooctanoic acid results in decreased expression of ZFP386 mRNA | CTD | PMID:19162173 | phenylmercury acetate | multiple interactions | ISO | ZNF519 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF519 mRNA | CTD | PMID:27188386 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of ZFP386 mRNA | CTD | PMID:18301758 | pirinixic acid | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | pirinixic acid results in decreased expression of ZFP386 mRNA | CTD | PMID:19162173 and PMID:22484513 | SB 431542 | multiple interactions | ISO | ZNF519 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of ZFP386 mRNA | CTD | PMID:19073995 | succimer | multiple interactions | ISO | ZNF519 (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF519 mRNA | CTD | PMID:26378955 | sunitinib | decreases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of ZNF519 mRNA | CTD | PMID:31533062 | thioacetamide | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of ZFP386 mRNA | CTD | PMID:34492290 | trichloroethene | decreases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of ZFP386 mRNA | CTD | PMID:33387578 | valproic acid | decreases methylation | ISO | ZNF519 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of ZNF519 gene | CTD | PMID:29154799 | valproic acid | affects splicing | ISO | Zfp386 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of ZFP386 mRNA | CTD | PMID:29427782 | valproic acid | multiple interactions | ISO | ZNF519 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ZNF519 mRNA | CTD | PMID:17183730 | valproic acid | decreases expression | ISO | ZNF519 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZNF519 mRNA | CTD | PMID:23179753 more ... | vinclozolin | increases expression | ISO | Zfp386 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of ZFP386 mRNA | CTD | PMID:23034163 | |